Current and historical daily PE Ratio for Akumin Inc (
) from 2017 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Akumin stock (TSX:AKU.U) PE ratio as of Jun 08 2024 is 0.
More Details
Akumin Inc (TSX:AKU.U) PE Ratio (TTM) Chart
Akumin Inc (TSX:AKU.U) PE Ratio (TTM) Historical Data
View and export this data going back to 2017. Start your Free Trial
Total 593
- 1
- 2
- 3
- 4
- 5
- 6
- 7
| Akumin PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-08 | At Loss | 2023-12-01 | At Loss |
| 2024-02-02 | At Loss | 2023-11-30 | At Loss |
| 2024-02-01 | At Loss | 2023-11-29 | At Loss |
| 2024-01-31 | At Loss | 2023-11-28 | At Loss |
| 2024-01-30 | At Loss | 2023-11-27 | At Loss |
| 2024-01-29 | At Loss | 2023-11-24 | At Loss |
| 2024-01-26 | At Loss | 2023-11-23 | At Loss |
| 2024-01-25 | At Loss | 2023-11-22 | At Loss |
| 2024-01-24 | At Loss | 2023-11-21 | At Loss |
| 2024-01-23 | At Loss | 2023-11-20 | At Loss |
| 2024-01-22 | At Loss | 2023-11-17 | At Loss |
| 2024-01-19 | At Loss | 2023-11-16 | At Loss |
| 2024-01-18 | At Loss | 2023-11-15 | At Loss |
| 2024-01-17 | At Loss | 2023-11-14 | At Loss |
| 2024-01-16 | At Loss | 2023-11-13 | At Loss |
| 2024-01-15 | At Loss | 2023-11-10 | At Loss |
| 2024-01-12 | At Loss | 2023-11-09 | At Loss |
| 2024-01-11 | At Loss | 2023-11-08 | At Loss |
| 2024-01-10 | At Loss | 2023-11-07 | At Loss |
| 2024-01-09 | At Loss | 2023-11-06 | At Loss |
| 2024-01-08 | At Loss | 2023-11-03 | At Loss |
| 2024-01-05 | At Loss | 2023-11-02 | At Loss |
| 2024-01-04 | At Loss | 2023-11-01 | At Loss |
| 2024-01-03 | At Loss | 2023-10-31 | At Loss |
| 2024-01-02 | At Loss | 2023-10-30 | At Loss |
| 2024-01-01 | At Loss | 2023-10-27 | At Loss |
| 2023-12-29 | At Loss | 2023-10-26 | At Loss |
| 2023-12-28 | At Loss | 2023-10-25 | At Loss |
| 2023-12-27 | At Loss | 2023-10-24 | At Loss |
| 2023-12-25 | At Loss | 2023-10-23 | At Loss |
| 2023-12-22 | At Loss | 2023-10-20 | At Loss |
| 2023-12-21 | At Loss | 2023-10-19 | At Loss |
| 2023-12-20 | At Loss | 2023-10-18 | At Loss |
| 2023-12-19 | At Loss | 2023-10-17 | At Loss |
| 2023-12-18 | At Loss | 2023-10-16 | At Loss |
| 2023-12-15 | At Loss | 2023-10-13 | At Loss |
| 2023-12-14 | At Loss | 2023-10-12 | At Loss |
| 2023-12-13 | At Loss | 2023-10-11 | At Loss |
| 2023-12-12 | At Loss | 2023-10-10 | At Loss |
| 2023-12-11 | At Loss | 2023-10-09 | At Loss |
| 2023-12-08 | At Loss | 2023-10-06 | At Loss |
| 2023-12-07 | At Loss | 2023-10-05 | At Loss |
| 2023-12-06 | At Loss | 2023-10-04 | At Loss |
| 2023-12-05 | At Loss | 2023-10-03 | At Loss |
| 2023-12-04 | At Loss | 2023-10-02 | At Loss |
Akumin Inc (TSX:AKU.U) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Akumin Inc
NAICS : 621512
SIC : 8071
ISIN : CA01021F1099
Share Class Description:
TSX:AKU.U: Ordinary SharesDescription
Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. The company's imaging procedures include MRI, CT, positron emission tomography, ultrasound, X-ray, mammography, and other diagnostic or interventional radiology procedures. It operates in two reportable business segments: radiology and oncology. The radiology segment acconts for majority revenue.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers